Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.98 USD | -0.39% | -0.64% | +24.59% |
May. 09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
May. 08 | Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.07B | MT |
Evolution of the average Target Price on Catalent, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Catalent, Inc.
Zacks Investment Research | |
UBS | |
Stephens Inc. | |
RBC Capital Markets | |
Deutsche Bank Securities | |
Barclays | |
Wells Fargo Securities | |
Baird | |
Argus | |
Morgan Stanley | |
JPMorgan Chase | |
Jefferies & Co. | |
BofA Securities | |
Nephron Research | |
William Blair & Co. | |
KeyBanc Capital Markets |
EPS Revisions
- Stock Market
- Equities
- CTLT Stock
- Consensus Catalent, Inc.